Navigation Links
Simvastatin Plus Niacin May Lower Heart Risks

Treatment combining the cholesterol drug simvastatin with the B vitamin niacin lowers the risk of heart attack and other artery-disease complications by up to 90% in some patients. The study of 160 adults with clogged heart arteries and low HDL (good) cholesterol showed that 3 years of the combo treatment improved HDL levels, caused artery blockages to recede and significantly lowered heart complications compared with an inactive placebo. //

Both lowering LDL, the "bad" cholesterol, and raising HDL help lower the risk of cardiac "events" such as heart attack. Brown, a researcher at the University of Washington in Seattle, and his colleagues reasoned that cutting LDL with a statin drug and raising HDL with niacin could potentially double the benefits for at-risk patients. And since low HDL may reflect an antioxidant deficiency, treatment with such vitamins could be expected to confer still more protection.

In the study, patients took either a combination of simvastatin (Zocor) and niacin alone, antioxidants alone, simvastatin-niacin plus antioxidants, or placebo. The antioxidant treatment included vitamins E, C, beta-carotene and selenium. Over 3 years, patients on simvastatin-niacin were 60% to 90% less likely than placebo patients to have a heart attack or stroke, need artery-clearing surgery or to die from causes related to their artery disease. These patients also showed a slight regression in their artery blockages, while on average all of the other groups showed worsening artery narrowing.

Patients on the combination plus antioxidants had more artery narrowing after 3 years and their HDL increases were not as strong compared with patients on simvastatin-niacin alone. Their risk of cardiac complications was lower, but not as low as that of patients on the combination alone. Treatment with antioxidants alone actually lowered an HDL component called HDL2 and did not cut patients' risk of heart attack and other complications.


'"/>




Related medicine news :

1. Ranbaxy Gets USFDA Nod For Simvastatin
2. Niacin Safe for Diabetics
3. Ritalin May Lower Cocaine Abuse
4. Eating More Often May Help Lower Cholesterol
5. Lower surgical volume linked to higher death rate
6. Lowering blood pressure beneficial for PAD patients
7. Lower chance of bone fracture with Vitamin D supplementation
8. Tea Pill Lowers Cholesterol
9. Aspirin Lowers Leukemia Risk
10. Almonds Help Lower Cholesterol
11. Lowering Risk of Breast Cancer Recurrence
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, ... M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... the most handsome men, look naturally attractive. Plastic surgery should be invisible.” He ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... , June 24, 2016 ... has announced the addition of the " Global ... This report ... provides an updated review, including its applications in various ... total market, which includes three main industries: pharmaceutical and ...
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
Breaking Medicine Technology: